Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
Reticulocyte Count
Comprehensive Metabolic Panel
Elastase, Pancreatic, Serum
Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Gene Mutation Analysis (Translocation)
Neurotrophic Receptor Tyrosine Kinase 3 (NTRK3) Gene Mutation Analysis (Translocation)
Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, GENESEEQPRIME™, Plasma Complete™)
Lead, Blood
Gamma Glutamyl Transferase (GGT)
Autoimmune Brain Panel (The Cunningham Panel™ for Autoimmune Neuropsychiatric Disorders)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Medical Test
Methodology
Access to
OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
is restricted.
Sign up now
Loading...